Accretion Pharmaceuticals Limited Share Price & Stock Analysis

Accretion Pharmaceuticals Limited engages in the manufacturing and marketing of pharmaceutical products in India. The company offers antibiotic, antibacterial, antifungal, anti-inflammatory, anti-spasmodic, antihistamine, antiallergy, anticough, anticold, antiulcer, gastrointestinal, antacid, anti-diabetic, cardiac, anti-hypertensive, psychotropic, memory enhancer, vitamins, supplements, and other products. It also provides external preparation, oral powder, effervescent formulation, and nutraceutical products, as well as formulations for brain and memory care, neuron care, UTI care, cardiac care, liver care, protein supplement, pediatric care, GIT care, joint and bone care, immunity booster, gynec care, hair and skin care, nail care, and infertility, and PCOS care. The company offers its products in the form of tablets, capsules, oral liquid, ointment, cream, gel, lotion, medicated shampoo, mouthwash, dusting powder, sachet, and dry syrup through contract manufacturing and direct sale

Key Metrics

Current Price₹193.20
Market Cap₹215 Cr
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Pharmaceuticals
P/E Ratio21.4
Beta (1Y)0.32

Business Segments

1. Manufacturing and Sale of Pharmaceutical Products-100%

Peer Companies

Frequently Asked Questions

What is the current share price of Accretion Pharmaceuticals Limited?

Accretion Pharmaceuticals Limited is trading at ₹193.20, with a market capitalisation of ₹215 Cr.

Which sector does Accretion Pharmaceuticals Limited belong to?

Accretion Pharmaceuticals Limited operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Pharmaceuticals).

What are the key financial ratios of Accretion Pharmaceuticals Limited?

Accretion Pharmaceuticals Limited has a P/E of 21.4.